5Folk R J, Jennette JC, Nachman PH.Membranous glomerulopathy. In: Brenner BM, ed. Brenner & Rector's The Kidney.6th ed. Philadelphia: W B Saunders,1999. 1284-1292.
6Ponticelli C, Passerini P. Membranous glomerulonephritis. In: Massry SG, Glassock RJ, eds. Massry & Glassock's Textbook of Nephrology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001. 707-713.
7Muirhead N. Management of idiopathic membranous nephropathy: evidence-based recommendations. Kidney Int, 1999, S70:S47-S55.
8Kida H, Asamoto T, Yokoyama H, et al.Long-term prognosis of idiopathic membranous nephropathy. Clin Nephrol, 1986,25: 64-69.
9Ponticelli C, Zucchelli P, Passerini P, et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int, 1995, 48: 1600-1604.
10Ponticelli C, Altieri P, Scolari F, et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol, 1998, 9: 444-450.
7Li LS, Liu ZH. Epidemiologic date of renal disease from a single unit in China: analysis based on 13519 renal biopsies[J]. Kidney Int, 2004, 66: 920-923.
8Katafuchi R, Kiyoshi Y, Oh Y, et al. Glomerular score as a prognostic factor in IgA nephropathy: its usefulness and limitation[J]. Clin Nephrol, 1998, 49: 1-8.
9Zent R, Nagai R, Cattran DC. Idiopathic membranous nephropathy in the elderly: a comparative study[J]. Am J Kidney Dis, 1997, 29: 200-206.
10Perry HM Jr, Miller JP, Fornoff JR, et al. Early predictors of 15- year end- stage renal disease in hypertensive pattents[J]. Hypertention, 1995, 25: 587-594.
